To query if anti-Müllerian hormone (AMH) and/or follicle stimulating hormone (FSH) predict live birth at University of Colorado Advanced Reproductive Medicine (CU ARM). We used the 2017-2019 Society for Assisted Reproductive Technology Clinical Outcomes Reporting System to identify all CU ARM autologous oocyte cycles. Donor gametes and frozen oocytes were excluded. The pregnancy outcome was recorded from the initial fresh or frozen embryo transfer. Multivariable linear regression was used to compare log AMH or FSH levels across pregnancy outcomes after adjusting for age categories including <35 years, 35-37 years, 38-40 years, 41-42 years, and >42 years. AMH or FSH values (n=988 cycles from 457 patients) were recorded for 255 transfers. The live birth (L/B) rate was 57.3% (146/255), which declined with increasing age group (p=0.008). Spontaneous abortion (SAB) rate was 12.9% (33/255), and the remaining 29.8% of transfers (76/255) were unsuccessful (N/E). The average AMH values did not differ among pregnancy outcomes after adjusting for age groups (p=0.51). FSH values, on the other hand, were on average 15% lower in the SAB group (geometric mean ratio=0.85, 95% CI: 0.75-0.97, p=0.014). Minimum observed AMH achieving a L/B increased with increasing age groups. Maximum FSH achieving a L/B had no trend across age groups. AMH and FSH are poor independent predictors of L/B after assisted reproductive technology (ART).